Chelatases: distort to select?

被引:87
作者
Al-Karadaghi, S
Franco, R
Hansson, M
Shelnutt, JA
Isaya, G
Ferreira, GC [1 ]
机构
[1] Univ S Florida, Coll Med, Dept Biochem & Mol Biol, Tampa, FL 33612 USA
[2] Lund Univ, Dept Mol Biophys, SE-22100 Lund, Sweden
[3] Lund Univ, Dept Biochem, SE-22100 Lund, Sweden
[4] Univ Nova Lisboa, Fac Ciencias & Tecnol, Dept Quim, Ctr Quim Fina & Biotecnol,REQUIMTE, P-2829516 Caparica, Portugal
[5] Sandia Natl Labs, Surface & Interface Sci Dept, Albuquerque, NM 87185 USA
[6] Univ Georgia, Dept Chem, Athens, GA 30602 USA
[7] Mayo Clin & Mayo Fdn, Coll Med, Dept Pediat & Adolescent Med, Rochester, MN 55905 USA
[8] Mayo Clin & Mayo Fdn, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA
[9] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33612 USA
[10] Univ S Florida, Res Inst, Tampa, FL 33612 USA
关键词
D O I
10.1016/j.tibs.2006.01.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Chelatases catalyze the insertion of a specific metal ion into porphyrins, a key step in the synthesis of metalated tetrapyrroles that are essential for many cellular processes. Despite apparent common structural features among chelatases, no general reaction mechanism accounting for metal ion specificity has been established. We propose that chelatase-induced distortion of the porphyrin substrate not only enhances the reaction rate by decreasing the activation energy of the reaction but also modulates which divalent metal ion is incorporated into the porphyrin ring. We evaluate the recently recognized interaction between ferrochelatase and frataxin as a way to regulate iron delivery to ferrochelatase, and thus iron and heme metabolism. We postulate that the ferrochelatase-frataxin interaction controls the type of metal ion that is delivered to ferrochelatase.
引用
收藏
页码:135 / 142
页数:8
相关论文
共 53 条
  • [1] Crystal structure of ferrochelatase: the terminal enzyme in heme biosynthesis
    Al-Karadaghi, S
    Hansson, M
    Nikonov, S
    Jonsson, B
    Hederstedt, L
    [J]. STRUCTURE, 1997, 5 (11) : 1501 - 1510
  • [2] Alternative modes of substrate distortion in enzyme and antibody catalyzed ferrochelation reactions
    Blackwood, ME
    Rush, TS
    Romesberg, F
    Schultz, PG
    Spiro, TG
    [J]. BIOCHEMISTRY, 1998, 37 (03) : 779 - 782
  • [3] A story of chelatase evolution -: Identification and characterization of a small 13-15-kda "ancestral" cobaltochelatase (CbiXs) in the archaea
    Brindley, AA
    Raux, E
    Leech, HK
    Schubert, HL
    Warren, MJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (25) : 22388 - 22395
  • [4] Frataxin acts as an iron chaperone protein to modulate mitochondrial aconitase activity
    Bulteau, AL
    O'Neill, HA
    Kennedy, MC
    Ikeda-Saito, M
    Isaya, G
    Szweda, LI
    [J]. SCIENCE, 2004, 305 (5681) : 242 - 245
  • [5] DAILEY HA, 2003, PORPHYRIN HDB, V12, P93
  • [6] Crystal structure of human frataxin
    Dhe-Paganon, S
    Shigeta, R
    Chi, YI
    Ristow, M
    Shoelson, SE
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (40) : 30753 - 30756
  • [7] NPAS2: A gas-responsive transcription factor
    Dioum, EM
    Rutter, J
    Tuckerman, JR
    Gonzalez, G
    Gilles-Gonzalez, MA
    McKnight, SL
    [J]. SCIENCE, 2002, 298 (5602) : 2385 - 2387
  • [8] Unraveling the substrate-metal binding site of ferrochelatase: An X-ray absorption spectroscopic study
    Ferreira, GC
    Franco, R
    Mangravita, A
    George, GN
    [J]. BIOCHEMISTRY, 2002, 41 (15) : 4809 - 4818
  • [9] FERREIRA GC, 1988, J BIOL CHEM, V263, P3835
  • [10] DEFINITIVE EVIDENCE FOR EXISTENCE OF SITTING-ATOP PORPHYRIN COMPLEXES IN NON-AQUEOUS SOLUTIONS
    FLEISCHER, EB
    DIXON, F
    [J]. BIOINORGANIC CHEMISTRY, 1977, 7 (02): : 129 - 139